BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15890564)

  • 1. Separation and identification of F2-isoprostane regioisomers and diastereomers by novel liquid chromatographic/mass spectrometric methods.
    Yin H; Porter NA; Morrow JD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):157-64. PubMed ID: 15890564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of F(2)-isoprostane isomers in cultured human lung epithelial cells after silica oxide and metal oxide nanoparticle treatment by liquid chromatography/tandem mass spectrometry.
    Liu X; Whitefield PD; Ma Y
    Talanta; 2010 Jun; 81(4-5):1599-606. PubMed ID: 20441945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key issues in F2-isoprostane analysis.
    Nourooz-Zadeh J
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):1060-5. PubMed ID: 18793189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo.
    Yin H; Musiek ES; Gao L; Porter NA; Morrow JD
    J Biol Chem; 2005 Jul; 280(28):26600-11. PubMed ID: 15894799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and relative quantitation of F2-isoprostane regioisomers formed in vivo in the rat.
    Waugh RJ; Morrow JD; Roberts LJ; Murphy RC
    Free Radic Biol Med; 1997; 23(6):943-54. PubMed ID: 9378374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry.
    Davies SS; Zackert W; Luo Y; Cunningham CC; Frisard M; Roberts LJ
    Anal Biochem; 2006 Jan; 348(2):185-91. PubMed ID: 16309621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of prolonged gradient separation for high-performance liquid chromatography-tandem mass spectrometry quantitation of plasma total 15-series F-isoprostanes.
    Taylor AW; Bruno RS; Frei B; Traber MG
    Anal Biochem; 2006 Mar; 350(1):41-51. PubMed ID: 16448621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F2-isoprostanes as markers of oxidative stress in vivo: an overview.
    Milne GL; Musiek ES; Morrow JD
    Biomarkers; 2005 Nov; 10 Suppl 1():S10-23. PubMed ID: 16298907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoprostanes: markers and mediators of oxidative stress.
    Montuschi P; Barnes PJ; Roberts LJ
    FASEB J; 2004 Dec; 18(15):1791-800. PubMed ID: 15576482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometric quantification of F2-isoprostanes as indicators of oxidant stress.
    Morrow JD; Roberts LJ
    Methods Mol Biol; 2002; 186():57-66. PubMed ID: 12013785
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress.
    Milne GL; Yin H; Brooks JD; Sanchez S; Jackson Roberts L; Morrow JD
    Methods Enzymol; 2007; 433():113-26. PubMed ID: 17954231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing levuglandins produced through the cyclooxygenase and isoprostane pathways.
    Salomon RG
    Chem Phys Lipids; 2005 Mar; 134(1):1-20. PubMed ID: 15752459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous measurement of F2-isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples.
    Yoshida Y; Kodai S; Takemura S; Minamiyama Y; Niki E
    Anal Biochem; 2008 Aug; 379(1):105-15. PubMed ID: 18482573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme immunoassay of isoprostanes.
    Callewaert DM; Sloan C
    Methods Mol Biol; 2010; 610():435-49. PubMed ID: 20013194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro lipid peroxidation of arachidonate esters: the effect of fish oil omega-3 lipids on product distribution.
    Davis TA; Gao L; Yin H; Morrow JD; Porter NA
    J Am Chem Soc; 2006 Nov; 128(46):14897-904. PubMed ID: 17105300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC-MS/MS methods for the detection of isoprostanes (iPF2alpha-III and 8,12-iso-iPF2alpha-VI) as biomarkers of CCl4-induced oxidative damage to hepatic tissue.
    Sicilia T; Mally A; Schauer U; Pähler A; Völkel W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):48-55. PubMed ID: 18160027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous analysis of multiple lipid oxidation products in vivo by liquid chromatographic-mass spectrometry (LC-MS).
    Yin H; Davis T; Porter NA
    Methods Mol Biol; 2010; 610():375-86. PubMed ID: 20013190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of urinary F2-isoprostanes with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry Application to polytraumatized patients.
    Mas E; Michel F; Guy A; Bultel V; Falquet Y; Chardon P; Rossi JC; Cristol JP; Durand T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):133-40. PubMed ID: 18706873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of F(2)-isoprostanes unveils profound oxidative stress in aged rats.
    Roberts LJ; Reckelhoff JF
    Biochem Biophys Res Commun; 2001 Sep; 287(1):254-6. PubMed ID: 11549283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereodivergent synthesis of all 15-F(2) isoprostanes.
    Schrader TO; Snapper ML
    J Am Chem Soc; 2002 Sep; 124(37):10998-1000. PubMed ID: 12224945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.